Literature DB >> 21628622

Frequency of herpes zoster recurrence.

Antonio Volpi, Antonio Gatti, Francesca Pica.   

Abstract

Mesh:

Year:  2011        PMID: 21628622      PMCID: PMC3104921          DOI: 10.4065/mcp.2011.0096

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  5 in total

1.  Herpes zoster recurrences more frequent than previously reported.

Authors:  Barbara P Yawn; Peter C Wollan; Marge J Kurland; Jennifer L St Sauver; Patricia Saddier
Journal:  Mayo Clin Proc       Date:  2011-01-10       Impact factor: 7.616

2.  A study of shingles and the development of postherpetic neuralgia in East London.

Authors:  Fiona T Scott; Mary E Leedham-Green; Winsome Y Barrett-Muir; Khidir Hawrami; W Jane Gallagher; Robert Johnson; Judith Breuer
Journal:  J Med Virol       Date:  2003       Impact factor: 2.327

3.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  M N Oxman; M J Levin; G R Johnson; K E Schmader; S E Straus; L D Gelb; R D Arbeit; M S Simberkoff; A A Gershon; L E Davis; A Weinberg; K D Boardman; H M Williams; J Hongyuan Zhang; P N Peduzzi; C E Beisel; V A Morrison; J C Guatelli; P A Brooks; C A Kauffman; C T Pachucki; K M Neuzil; R F Betts; P F Wright; M R Griffin; P Brunell; N E Soto; A R Marques; S K Keay; R P Goodman; D J Cotton; J W Gnann; J Loutit; M Holodniy; W A Keitel; G E Crawford; S-S Yeh; Z Lobo; J F Toney; R N Greenberg; P M Keller; R Harbecke; A R Hayward; M R Irwin; T C Kyriakides; C Y Chan; I S F Chan; W W B Wang; P W Annunziato; J L Silber
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

4.  No evidence of family history as a risk factor for herpes zoster in patients with post-herpetic neuralgia.

Authors:  A Gatti; F Pica; M T Y Boccia; F De Antoni; A F Sabato; A Volpi
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

5.  Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Rafael Harpaz; Ismael R Ortega-Sanchez; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2008-06-06
  5 in total
  4 in total

Review 1.  Reducing the burden of Herpes Zoster in Italy.

Authors:  Giovanni Gabutti; Elisabetta Franco; Paolo Bonanni; Michele Conversano; Antonio Ferro; Marzia Lazzari; Stefania Maggi; Alessandro Rossi; Silvestro Scotti; Francesco Vitale; Antonio Volpi; Donato Greco
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

2.  Periodicity of varicella-zoster virus in the presence of immune boosting and clinical reinfection with varicella.

Authors:  Igor A Korostil; James G Wood; David G Regan
Journal:  Theor Biol Med Model       Date:  2015-04-11       Impact factor: 2.432

3.  Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial.

Authors:  Olivier Godeaux; Martina Kovac; Daniel Shu; Katrijn Grupping; Laura Campora; Martine Douha; Thomas C Heineman; Himal Lal
Journal:  Hum Vaccin Immunother       Date:  2017-01-09       Impact factor: 3.452

4.  Frequency of Herpes Zoster Recurrence in Central District of Korea.

Authors:  Jae Won Ha; Jin Yong Lee; Young Her; Chul Woo Kim; Sang Seok Kim
Journal:  Ann Dermatol       Date:  2017-08-25       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.